Phoenix Bio

研究開発

研究開発

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C Virus and its susceptibility to interferon

    Hiraga N, Imamura M, Tsuge M, Noguchi C, Takahashi S, Iwao E, Fujimoto Y, Abe H, Maekawa T, Ochi H, Tateno C, Yoshizato K, Sakai A, Sakai Y, Honda M, Kaneko S, Wakita T, Chayama K.
    FEBS Lett. 2007 May 15;581(10):1983-7. Epub 2007 Apr 20.

    Evaluation of Cyclophilin Inhibitor in Hepatitis C Virus-Infected Chimeric Mice In Vivo

      Inoue K, Umehara T, Ruegg UT, Yasui F, Watanabe T, Yasuda H, Dumont JM, Scalfaro P, Yoshiba M, Kohara M.
      Hepatology. 2007 Apr;45(4):921-8.

      Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice

        Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M.
        Biochem Biophys Res Commun. 2007 Feb 23;353(4):882-8. Epub 2006 Dec 22.

        Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model

          Umehara T, Sudoh M, Yasui F, Matsuda C, Hayashi Y, Chayama K, Kohara M.

          Biochem Biophys Res Commun. 2006 Jul 21;346(1):67-73. Epub 2006 May 24.